Fortress Biotech, Inc. Logo

Fortress Biotech, Inc.

Biopharmaceutical firm that develops and commercializes a diversified drug portfolio.

FBIO | US

Overview

Corporate Details

ISIN(s):
US34960Q3074 (+1 more)
LEI:
Country:
United States of America
Address:
1111 KANE CONCOURSE, 33154 BAY HARBOR ISLANDS

Description

Fortress Biotech is an innovative biopharmaceutical company that acquires, develops, and commercializes pharmaceutical products. The company operates through a network of subsidiary and partner companies to advance a diversified portfolio. This portfolio includes revenue-generating commercial products, primarily in dermatology, and a robust pipeline of development-stage candidates. The clinical pipeline spans multiple therapeutic areas, including rare diseases, oncology, gene therapy, neurology, and pain management. Key development programs are focused on conditions such as Menkes disease, AL amyloidosis, and glioblastoma, utilizing advanced modalities like CAR-T cell therapies, oncolytic viruses, and gene therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Fortress Biotech, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fortress Biotech, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fortress Biotech, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.